A study of more than 10,000 postmenopausal women who underwent hysterectomy showed that estrogen-only hormone therapy did not increase the risk of death from lung cancer.
Published in Brief:
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Chief Medical Officer, Texas Children's Health Plan||
Cejka Executive Search for Texas Childre's Health Plan
|Chief Financial Officer||
B. E. Smith
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|